Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Asia-Pacific Journal of Clinical Oncology|April 15, 2021
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in AustraliaArlene Chan, Christopher Lomma, HuiJun Chih, et al.Oncotarget|November 29, 2016
Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapiesMichael S Shawky, Hilary Martin, Honor J Hugo, et al.Breast Cancer Research and Treatment|April 13, 2019
The association between mammographic density and breast cancer risk in Western Australian Aboriginal womenEllie Darcey, Rachel Lloyd, Gemma Cadby, et al.Asia-Pacific Journal of Clinical Oncology|January 31, 2026
Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in AustraliaAndrew Redfern, Elgene Lim, Sunil Lakhani, et al.African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|July 2, 2025
Characteristics and outcomes of children initiated on high flow nasal cannula and continuous positive airway pressure at the emergency centre of a district hospital in South AfricaJessica Head, Andrew Redfern, Jana Hoole, et al.Urology Case Reports|September 12, 2025
Urothelial carcinoma in situ of the entire urinary tract with invasion into seminal vesicle: A case reportVivien Wei-Anne Hsu, Nicole Swarbrick, Hemant Kulkarni, et al.Journal of Shoulder and Elbow Surgery|May 26, 2018
A randomized controlled trial of arthroscopic capsular release versus hydrodilatation in the treatment of primary frozen shoulderSian Gallacher, James C Beazley, Jon Evans, et al.Asia-Pacific Journal of Clinical Oncology|October 6, 2018
Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancerElgene Lim, Jane Beith, Frances Boyle, et al.European Journal of Clinical Pharmacology|July 12, 2023
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell diseaseChristina Lourdes Mayer, Kathleen Koeck, Margot Hottmann, et al.Cancers|March 11, 2023
Association of Computed Tomography Measures of Muscle and Adipose Tissue and Progressive Changes throughout Treatment with Clinical Endpoints in Patients with Advanced Lung Cancer Treated with Immune Checkpoint InhibitorsAzim Khan, Christopher J Welman, Afaf Abed, et al.Pageof 8